IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Anthera Pharmaceuticals
Symbol: ANTH
Price: Last trade $4.77
Trade Date: 3/18
Shares: 5.2 million
Underwriter(s) Piper Jaffray
Rating=Subscription Needed
Company: RSP Permian, Inc.-BLOCK
Symbol: RSPP
Price: Last trade $27.07
Trade Date: 3/18
Shares: 9 million
Underwriter(s) Barclays
Rating=Subscription Needed
Secondaries announced 3.17.15